ArticleBiomaterials2025

Corrigendum to "Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy" [Biomaterials 312 (2025) 122750.

Mostafa Yazdimamaghani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.